| Current Price | $54.73 | Mkt Cap | $9.0B |
|---|---|---|---|
| Open | $54.61 | P/E Ratio | 31.41 |
| Prev. Close | $54.48 | Div. (Yield) | $0.32 (0.6%) |
| Daily Range | $54.35 - $54.80 | Volume | 77,096 |
| 52-Wk Range | $49.59 - $58.28 | Avg. Daily Vol. | 179,760 |
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
| Current Price | $54.73 | Mkt Cap | $9.0B |
|---|---|---|---|
| Open | $54.61 | P/E Ratio | 31.41 |
| Prev. Close | $54.48 | Div. (Yield) | $0.32 (0.6%) |
| Daily Range | $54.35 - $54.80 | Volume | 77,096 |
| 52-Wk Range | $49.59 - $58.28 | Avg. Daily Vol. | 179,760 |
The best Bull and Bear pitches based on recency and number of recommendations.
40% of patents on proprietary drugs will expire by 2014. This stunning figure should be a windfall for Dr. Reddy's, which specializes in generics. Add to this the cheap costs of labor in India, and innovative model practiced by management, and we… More
Read the most recent pitches from players about RDY.
Recs
Recs
TMFjimhalley
(< 20)
Submitted: 5/5/2021 8:40:36 PM :
Start Price:
$68.91
NYSE:RDY Score:
-14.96
Company has been increasing revenue, margins and profits but seems to be underpriced with a relatively low price-to-earnings ratio.
Recs
jfdihansen
(43.70)
Submitted: 11/22/2014 1:43:42 PM :
Start Price:
$54.55
NYSE:RDY Score:
-89.12
Net asset value is less that stock price
Find the members with the highest scoring picks in RDY.
01123581321 (33.16) Score: +312.57
The Score Leader is the player with the highest score across all their picks in RDY.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| athome4 | 54.49 | 10/10/2008 |
|
5Y | $7.13 | +667.20% | +364.10% | +303.10 | 0 Comment | |
| yeraz | 45.39 | 10/13/2008 |
|
5Y | $7.61 | +619.39% | +326.20% | +293.19 | 1 Comment | |
| niwhsa | 86.77 | 11/20/2008 |
|
3Y | $6.88 | +695.92% | +402.82% | +293.10 | 0 Comment | |
| MedullaOblongata | 72.21 |
|
|
5Y | $7.99 | +584.73% | +305.80% | +278.93 | 0 Comment | |
| XMFHamp | 99.93 | 10/9/2008 |
|
NS | $8.11 | +574.79% | +313.80% | +260.98 | 0 Comment | |
| biotech4ever | 21.63 | 3/20/2009 |
|
5Y | $7.25 | +654.89% | +407.16% | +247.73 | 0 Comment | |
|
snazzysnazz | 72.35 | 3/20/2009 |
|
5Y | $7.24 | +655.83% | +413.53% | +242.30 | 0 Comment |
| Trimalerus | 76.39 |
|
|
5Y | $7.38 | +641.20% | +403.64% | +237.56 | 1 Comment | |
| apodeictic | 28.24 | 10/22/2008 |
|
1Y | $8.23 | +564.63% | +331.78% | +232.84 | 0 Comment | |
| jenculbertson | 70.26 | 10/16/2008 |
|
1Y | $7.97 | +587.06% | +354.29% | +232.77 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
